Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.7377
+0.0295 (4.17%)
At close: Apr 27, 2026, 4:00 PM EDT
0.7126
-0.0251 (-3.40%)
After-hours: Apr 27, 2026, 7:48 PM EDT
Genenta Science Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Genenta Science in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Genenta Science.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,288.91% | Oct 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,288.91% | May 13, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +1,933.35% | Jun 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +3,288.91% | Feb 8, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +1,933.35% | Jan 5, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.47
from -0.33
EPS Next Year
-0.54
from -0.47
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue |
|---|
| High |
| Avg |
| Low |
Revenue Growth
| Revenue Growth |
|---|
| High |
| Avg |
| Low |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.48 | -0.56 |
| Avg | -0.47 | -0.54 |
| Low | -0.45 | -0.52 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.